An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Abed, Nadia ^a   Saïd Hassane, Fatouma ^a   Zouhiri, Fatima ^a   Mougin, Julie ^a   Nicolas, Valérie ^b   Desmaële, Didier ^a   Gref, Ruxandra ^a   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; NANOPARTICLE; PENICILLIN G;

ANIMAL; ANTIBIOTIC RESISTANCE; CELL DEATH; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ENDOCYTOSIS; GROWTH, DEVELOPMENT AND AGING; INTRACELLULAR SPACE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MOUSE; RAW 264.7 CELL LINE; STAPHYLOCOCCUS AUREUS; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CELL DEATH; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; ENDOCYTOSIS; INTRACELLULAR SPACE; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; NANOPARTICLES; PENICILLIN G; RAW 264.7 CELLS; STAPHYLOCOCCUS AUREUS;

EID: 84940556588     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13500     Document Type: Article

References (40)

1. Foster, T. J. Immune evasion by staphylococci. Nat Rev Microbiol 3, 948-958, doi: 10.1038/nrmicro1289 (2005).
2. Proctor, R. A. et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4, 295-305, doi: 10.1038/nrmicro1384 (2006).
3. Renard, C., Vanderhaeghe, H. J., Claes, P. J., Zenebergh, A. & Tulkens, P. M. Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother 31, 410-416 (1987).
4. Carryn, S. et al. Intracellular pharmacodynamics of antibiotics. Infect Dis Clin North Am 17, 615-634 (2003).
5. Tulkens, P. M. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis 10, 100-106 (1991).
6. Baharoglu, Z., Krin, E. & Mazel, D. RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae. PLoS Genet 9, e1003421, doi: 10.1371/journal.pgen.1003421 (2013).
7. Abed, N. & Couvreur, P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents 43, 485-496, doi: 10.1016/j.ijantimicag.2014.02.009 (2014).
8. Briones, E., Colino, C. I. & Lanao, J. M. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 125, 210-227 (2008).
9. Imbuluzqueta, E. et al. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin. J Antimicrob Chemother 67, 2158-2164, doi: 10.1093/jac/ dks172 (2012).
10. Xiong, M.-H., Bao, Y., Yang, X.-Z., Zhu, Y.-H. & Wang, J. Delivery of antibiotics with polymeric particles. Advanced Drug Delivery Reviews 78, 63-76, doi: 10.1016/j.addr.2014.02.002 (2014).
11. Lecaroz, C., Gamazo, C. & Blanco-Prieto, M. J. Nanocarriers with gentamicin to treat intracellular pathogens. J Nanosci Nanotechnol 6, 3296-3302 (2006).
12. Fattal, E., Youssef, M., Couvreur, P. & Andremont, A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother 33, 1540-1543 (1989).
13. Radovic-Moreno, A. F. et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6, 4279-4287, doi: 10.1021/nn3008383 (2012).
14. Toti, U. S. et al. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials 32, 6606-6613 (2011).
15. Xiong, M. H. et al. Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. J Am Chem Soc 134, 4355-4362, doi: 10.1021/ja211279u (2012).
16. Diacon, A. H. et al. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother 51, 2994-2996, doi: 10.1128/AAC.01474-06 (2007).
17. Ma, C., Zhang, F. Q. & Jin, Z. Global stability of a tuberculosis model with vertical transmission. Snpd 2007: Eighth Acis International Conference on Software Engineering, Artificial Intelligence, Networking, and Parallel/Distributed Computing. Vol 3, Proceedings, 508-511, doi: 10.1109/Snpd.2007.337 (2007).
18. Allison, S. D. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv 5, 615-628, doi: 10.1517/17425247.5.6.615 (2008).
19. Semiramoth, N. et al. Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano 6, 3820-3831 (2012).
20. Asari, F., Kusumi, T. & Kakisawa, H. Turbinaric acid, a cytotoxic secosqualene carboxylic acid from the brown alga Turbinaria ornata. J Nat Prod 52, 1167-1169 (1989).
21. Gershenzon, J. & Dudareva, N. The function of terpene natural products in the natural world. Nat Chem Biol 3, 408-414 (2007).
22. Sacchettini, J. C. & Poulter, C. D. Creating isoprenoid diversity. Science 277, 1788-1789 (1997).
23. Maksimenko, A. et al. Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Cancer Lett 334, 346-353, doi: 10.1016/j.canlet.2012.08.023 (2013).
24. Schnaith, A. et al. Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem 282, 2695-2706, doi: 10.1074/jbc.M609784200 (2007).
25. Dinges, M. M., Orwin, P. M. & Schlievert, P. M. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13, 16-34, table of contents (2000).
26. Gotz, F., Verheij, H. M. & Rosenstein, R. Staphylococcal lipases: molecular characterisation, secretion, and processing. Chem Phys Lipids 93, 15-25 (1998).
27. Tan, N. C. et al. Intracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis? Int Forum Allergy Rhinol 3, 261-266, doi: 10.1002/alr.21154 (2013).
28. Maya, S. et al. Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int J Biol Macromol 51, 392-399, doi: 10.1016/j.ijbiomac.2012.06.009 (2012).
29. Fontana, G., Licciardi, M., Mansueto, S., Schillaci, D. & Giammona, G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22, 2857-2865, doi: 10.1016/ S0142-9612 (2001).
30. Lismond, A., Tulkens, P. M., Mingeot-Leclercq, M. P., Courvalin, P. & Van Bambeke, F. Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin. Antimicrob Agents Chemother 52, 3040-3046, doi: 10.1128/AAC.00105-08 (2008).
31. Couvreur, P. et al. Squalenoyl nanomedicines as potential therapeutics. Nano Lett 6, 2544-2548, doi: 10.1021/nl061942q (2006).
32. Maksimenko, A. et al. A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. Proc Natl Acad Sci USA 111, E217-E226, doi: 10.1073/pnas.1313459110 (2014).
33. Bildstein, L. et al. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. J Control Release 147, 163-170, doi: 10.1016/j.jconrel.2010.07.120 (2010).
34. Kalluru, R. et al. Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes. J Cell Sci 126, 3043-3054, doi: 10.1242/jcs.121814 (2013).
35. Lepeltier, E., Bourgaux, C. & Couvreur, P. Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices. Adv Drug Deliv Rev 71, 86-97, doi: 10.1016/j.addr.2013.12.009 (2014).
36. Brook, I. The importance of lactic acid levels in body fluids in the detection of bacterial infections. Rev Infect Dis 3, 470-478 (1981).
37. Binderup, E. & Hansen, E. T. Chlorosulfates as Reagents in the Synthesis of Carboxylic-Acid Esters under Phase-Transfer Conditions. Synthetic Commun 14, 857-864, doi: 10.1080/00397918408075729 (1984).
38. Daehne, W. et al. Acyloxymethyl esters of ampicillin. J Med Chem 13, 607-612 (1970).
39. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63 (1983).
40. Kubica, M. et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 3, e1409 (2008).